Filter
1525
Filtered Results: 1525
Text search:
Anti-Tuberculosis
medicines
Featured
Recommendations
175
New Publications
476
Language
Document type
No document type
1019
Guidelines
178
Studies & Reports
174
Manuals
72
Strategic & Response Plan
32
Training Material
18
Fact sheets
14
Situation Updates
10
Infographics
5
Brochures
1
App
1
Resource Platforms
1
Countries / Regions
India
98
Kenya
50
Western and Central Europe
42
Ethiopia
41
Uganda
40
South Africa
35
Nigeria
33
Global
33
Tanzania
31
Zambia
29
Nepal
25
Ghana
25
Eastern Europe
24
Malawi
22
Liberia
22
Myanmar / Burma
21
Bangladesh
20
Namibia
19
Rwanda
18
Philippines
18
Ukraine
16
Sierra Leone
16
Africa
15
Asia
15
Latin America and the Carribbean
15
Lesotho
14
Russia
14
Cambodia
13
Colombia
10
Zimbabwe
10
South–East Asia Region
10
Senegal
9
Botswana
9
Indonesia
9
Mozambique
8
Venezuela
7
Germany
6
Eswatini/ Swaziland
6
Benin
5
Peru
5
Bolivia
5
Moldova
5
Pakistan
5
Tajikistan
4
Thailand
4
Cameroon
4
Syria
4
East and Southern Africa
4
Albania
3
Afghanistan
3
Paraguay
3
Vietnam
3
Ecuador
3
Timor Leste/ East Timor
2
Haiti
2
Jordan
2
West and Central Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Turkmenistan
2
Argentina
2
Lebanon
2
Papua New Guinea
2
Yemen
2
Georgia
2
Poland
2
Libya
2
Somalia
2
North Macedonia
1
El Salvador
1
Gambia
1
China
1
Chile
1
Iran
1
Laos
1
Estonia
1
Burkina Faso
1
Uzbekistan
1
Qatar
1
USA
1
Hungary
1
Saudi Arabia
1
Congo, Democratic Republic of
1
Western Pacific Region
1
North America
1
Denmark
1
Maldives
1
Southern Africa
1
Brazil
1
Sri Lanka
1
Djibouti
1
Egypt
1
Sudan
1
Palestine
1
Mali
1
Bhutan
1
South Sudan
1
Iraq
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
652
Clinical Guidelines
176
Public Health
74
Women & Child Health
50
Key Resources
25
Pharmacy & Technologies
24
Capacity Building
17
Toolboxes
TB
365
HIV
179
AMR
65
Pharmacy
62
COVID-19
39
NTDs
39
Mental Health
37
NCDs
24
Caregiver
22
Global Health Education
20
Refugee
16
Rapid Response
14
Ebola & Marburg
14
Conflict
13
Polio
13
Planetary Health
11
Health Financing Toolbox
8
Disability
7
Natural Hazards
6
Specific Hazards
3
Malaria
3
Cholera
1
Social Ethics
1
Zika
1
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guidelines are the first to be released under the rubric of the WHO consolidated TB guidelines, this handbook...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
Estas directrices sustituyen a los anteriores documentos de política de la OMS sobre el manejo de la ILTB en las personas con la infección por el VIH, los contactos del hogar de personas con TB y otros grupos de riesgo. Las Directrices unificadas de la OMS sobre la tuberculosis: Tratamiento preven...
El objetivo de este artículo es analizar las condiciones de acceso a servicios de salud de las personas con tuberculosis en América
Latina y el Caribe (ALC), reflexionando desde la bioética sobre los aspectos de salud pública implicados. Se realizó una revisión
documental del contexto de la ...
6 July 2021. The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection 2021 update” is the latest document replacing the one issued in 2020. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included in the...
The goal of this addendum is to help management and staff
minimize the risk of TB transmission at facilities in resource limited settings in which a.) HIV-infected persons receive diagnosis, care, treatment,
and/or support, and b.) there is a high prevalence of HIV infection, both known
and...
Rev Panam Salud Publica. 2021;45:e74.
Some characteristics of patients and healthcare providers influence treatment success in MDR-TB cases. Physicians’ and nurses’ knowledge about MDR-TB must be improved, and follow-up of MDR-TB patients who are living with HIV and of those affiliated with the...
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e...
Advances in Infectious Diseases, 2015, 5, 57-62
Published Online March 2015 in SciRes.
BMC Infectious Diseases 2012, 12:352/1471-2334/12/352
